US20030167133A1 - Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent thereby - Google Patents

Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent thereby Download PDF

Info

Publication number
US20030167133A1
US20030167133A1 US10/340,461 US34046103A US2003167133A1 US 20030167133 A1 US20030167133 A1 US 20030167133A1 US 34046103 A US34046103 A US 34046103A US 2003167133 A1 US2003167133 A1 US 2003167133A1
Authority
US
United States
Prior art keywords
bioagent
nucleic acid
database
method
molecular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/340,461
Inventor
David Ecker
Richard Griffey
Rangarajan Sampath
Steven Hofstadler
John McNeil
Stanley Crooke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ibis Biosciences Inc
Original Assignee
Ionis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US09/891,793 priority Critical patent/US7217510B2/en
Application filed by Ionis Pharmaceuticals Inc filed Critical Ionis Pharmaceuticals Inc
Priority to US10/340,461 priority patent/US20030167133A1/en
Assigned to ISIS PHARMACEUTICALS, INC. reassignment ISIS PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ECKER, DAVID J., HOFSTADLER, STEVEN A., GRIFFEY, RICHARD H., MCNEIL, JOHN, SAMPATH, RANGARAJAN, CROOKE, STANLEY T.
Publication of US20030167133A1 publication Critical patent/US20030167133A1/en
Assigned to IBIS BIOSCIENCES, INC. reassignment IBIS BIOSCIENCES, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ISIS PHARMACEUTICALS, INC.
Application status is Abandoned legal-status Critical

Links